Ovarian cancer: new clinical approaches
- 31 March 1991
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 18, 77-83
- https://doi.org/10.1016/0305-7372(91)90027-w
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1989
- Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinomaGynecologic Oncology, 1989
- Enhanced DNA repair and resistance to cisplatin in human ovarian cancerBiochemical Pharmacology, 1988
- Role of Hexamethylmelamine in the Treatment of Ovarian Cancer: Where is the Needle in the Haystack?JNCI Journal of the National Cancer Institute, 1988
- Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathioneBiochemical Pharmacology, 1987
- Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletionBiochemical Pharmacology, 1985